Cargando…
Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in Shenzhen, China: a retrospective cohort study
BACKGROUND: WHO recommended multidrug-resistant tuberculosis (MDR-TB) should be treated mainly under ambulatory model, but outcome of ambulatory treatment of MDR-TB in China was little known. METHODS: The clinical data of 261 MDR-TB patients treated as outpatients in Shenzhen, China during 2010–2015...
Autores principales: | Lecai, Ji, Mijiti, Peierdun, Chuangyue, Hong, Qian, Gao, Weiguo, Tan, Jihong, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319049/ https://www.ncbi.nlm.nih.gov/pubmed/37408751 http://dx.doi.org/10.3389/fpubh.2023.1134938 |
Ejemplares similares
-
Predictors and Trends of MDR/RR-TB in Shenzhen China: A Retrospective 2012–2020 Period Analysis
por: Lecai, Ji, et al.
Publicado: (2021) -
Association of in vitro fertilization with maternal and perinatal outcomes among pregnant women with active tuberculosis: A retrospective hospital-based cohort study
por: Xia, Lu, et al.
Publicado: (2022) -
Time-trend analysis of tuberculosis diagnosis in Shenzhen, China between 2011 and 2020
por: Hong, Chuang-Yue, et al.
Publicado: (2023) -
A population-based genomic epidemiological study of the source of tuberculosis infections in an emerging city: Shenzhen, China
por: Yang, Tingting, et al.
Publicado: (2021) -
Treatment cost assessment for COVID-19 inpatients in Shenzhen, China 2020–2021: facts and suggestions
por: Yuan, Shasha, et al.
Publicado: (2023)